These medications help regulate blood sugar by stimulating insulin production and suppressing appetite, making them invaluable tools for weight loss and diabetes management
Su KZ, Li YR, Zhang D, Yuan JH, Zhang CS, Liu Y, Song LM, Lin Q, Li MW, Dong J (2019) Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and Meta-analysis
the risk of more severe side effects is low
The state Senate Health and Welfare Committee moved forward Wednesday with Senate Bill 433, which would allow adults with a body mass index of 35 to 39 to access what are known as GLP-1 drugs for obesity if they have another chronic condition, or comorbidity, including prediabetes, hypertension or cardiovascular disease